Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 5, 1999, Pages 645-649

  Hoellman, Dianne B ^a   Lin, Gengrong ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS INFECTION; TIME;

AMOXICILLIN; ANTI-INFECTIVE AGENTS; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORINS; CIPROFLOXACIN; CLARITHROMYCIN; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; OFLOXACIN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032898685     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.5.645     Document Type: Article

References (23)

1. Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae - an overview. Clinical Infectious Diseases 15, 77-83.
2. Friedland, I. R. & Istre, G. R. (1992). Management of penicillin-resistant pneumococcal infections. Pediatric Infectious Disease Journal 11, 433-5.
3. Jacobs, M. R. (1992). Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clinical Infectious Diseases 15, 119-27.
4. Jacobs, M. R. & Appelbaum, P. C. (1995). Antibiotic-resistant pneumococci. Reviews of Medical Microbiology 6, 77-93.
5. Breiman, R. F., Butler, J. C., Tenover, F. C., Elliott, J. A. & Facklam, R. R. (1994). Emergence of drug-resistant pneumococcal infections in the United States. Journal of the American Medical Association 271, 1831-5.
6. Doern, G. V., Brueggemann, A., Holley, H. P. & Rauch, A. M. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, 1208-13.
7. Block, S. L., Harrison, C. J., Hedrick, J. A., Tyler, R. D., Smith, R. A., Keegan, E. et al. (1995). Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatric Infectious Disease Journal 14, 751-9.
8. Friedland, I. R. & McCracken, G. H. (1994). Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New England Journal of Medicine 331, 377-82.
9. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1995). Activity of CP 99,219 compared to DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, spartloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 35, 230-2.
10. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1992). Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, WIN 57273, ofloxacin and ciprofloxacin. Antimicrobial Agents and Chemotherapy 36, 856-9.
11. Spangler, S. K., Jacobs, M. R., Pankuch, G. A. & Appelbaum, P. C. (1993). Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. Journal of Antimicrobial Chemotherapy 31, 273-80.
12. Hosaka, M., Kinoshita, S., Toyama, A., Otsuki, M. & Nishino, T. (1995). Antibacterial properties of AM-1155, a new 8-methoxy quinolone. Journal of Antimicrobial Chemotherapy 36, 293-301.
13. Hosaka, M., Yasue, T., Fukuda, H., Tomizawa, H., Aoyama, H. & Hirai, K. (1992). In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrobial Agents and Chemotherapy 36, 2108-17.
14. Nakashima, M., Uematsu, T., Kosuge, K., Kusajima, H., Ooie, T., Masuda, Y. et al. (1995). Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrobial Agents and Chemotherapy 39, 2635-40.
15. Wakabayashi, E. & Mitsuhashi, S. (1994). In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrobial Agents and Chemotherapy 38, 594-601.
16. Wise, R., Brenwald, N. P., Andrews, J. M. & Boswell, F. (1997). The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. Journal of Antimicrobial Chemotherapy 39, 447-52.
17. Bauernfeind, A. (1997). Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. Journal of Antimicrobial Chemotherapy 40, 639-51.
18. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA.
19. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1994). Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin and vancomycin by using time-kill methodology. Antimicrobial Agents and Chemotherapy 38, 2065-72.
20. Pankuch, G. A., Lichtenberger, C., Jacobs, M. R. & Appelbaum, P. C. (1996). Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrobial Agents and Chemotherapy 40, 1653-6.
21. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1995). Comparative activity of ampicillin, amoxycillin, amoxycillin/ clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 35, 883-8.
22. Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1996). MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrobial Agents and Chemotherapy 40, 362-6.
23. Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1997). Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral β-lactams. Antimicrobial Agents and Chemotherapy 41, 2786-9.